Theravance Biopharma, Inc. (NASDAQ: TBPH) reported financial results for the second quarter 2014, and provided a corporate update. Revenue for the second quarter of 2014 was $3.0 million. Net loss for the second quarter of 2014 was $58.2 million or $1.83 per share. Cash, cash equivalents, and marketable securities totaled $387.4 million as of June 30, 2014. Theravance Biopharma, Inc. (NASDAQ:TBPH) belongs to Healthcare sector. … Continue reading Hot Stock List: Theravance Biopharma (NASDAQ:TBPH), Criteo (NASDAQ:CRTO), Majesco Entertainment (NASDAQ:COOL), Glimcher Realty Trust (NYSE:GRT), GenCorp Inc. (NYSE:GY)